This is the authors' abstract. We don't add key points for this paper.
Our group has previously described a particular form of Hepatocellular carcinoma (HCC) developed in non-cirrhotic liver (HCC-NC) developed in Peruvian patients Our aim is to analyze the HCC-NC from clinical-biological findings in two different cohorts (Peruvian and French) and the link with metallomic profile. Clinical, histopathological and also tumoral (T) and non-tumoral liver (NTL) samples of 38 Peruvian and 45 French patients were studied. Twelve metals were assayed using ICP/MS: Mn, Fe, Cu, Co, Zn, As, Se, Rb, Mo, Cd, Pb, and Sn. Possible associations between metals and survival were also evaluated. Overall, results show clearly differences between both cohorts. Mean age were 41 ± 20 and 68 ± 9 years-old for Peruvians and French, respectively. 80% of Peruvian patients were positive for the HBsAg, versus 9% in French patients. Metals concentrations were higher in the NTL of Peruvians (p < 0.05) compared to the French. In both cohort metal concentrations were lower in HCC areas compared to NTL, excepted for Cu for which mean concentration was increased in HCC (p < 0.05). Se concentration in HCC was associated with better survival only in Peruvians. Our data shows, in both HCC-NC cohorts, that the process of hepatic tumorigenesis impact similarity the metallomic profile in tumor.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cano et al. (2020) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: